2026-01-28 - Analysis Report
**UnitedHealth Group UNH Stock Analysis**

### 1. Return Rate Comparison

* Ticker: UNH
* Company Name: UnitedHealth Group
* Cumulative return of review stock: 12.38%
* Cumulative return of comparison stock (S&P 500, VOO): 128.51%
* Divergence (max: 105.40, min: -114.30, current: -88.10, relative divergence: 11.90%)

### Analysis

The cumulative return of UnitedHealth Group (12.38%) is significantly lower than the S&P 500 (128.51%). The divergence between the two stocks is currently at -88.10, indicating a moderate negative performance. However, the relative divergence is 11.90%, which means it is still in the lower range of past fluctuations.

### 2. Recent Stock Price Fluctuations

* Close: $282.70
* Last-market: 
  - Price: 282.7
  - Previous Close: 351.64
  - Change: -19.61
* 5-day SMA: $338.56
* 20-day SMA: $338.09
* 60-day SMA: $331.43

### Analysis

The stock has recently experienced a sharp decline, with a 20-day change of -19.61. The 5-day, 20-day, and 60-day moving averages are all above the current close, indicating a potential rebound in the short term.

### 3. RSI, PPO, and Delta_Previous_Relative_Divergence Indicators

* RSI: 25.83
* PPO: -0.88
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: Medium (MRI 0.70)
* Recent (20 days) relative divergence change: 3.50 (+): improving
* 7-day Rank change: 49 (+): rank up
* 7-day Dynamic Expected Return change: 454.30 (+): improving
* Expected Return (%): 239.30%

### Analysis

The RSI and PPO indicators suggest a strongly oversold condition, with the stock potentially due for a rebound. The hybrid signal is buy, and the risk level is medium. The expected return is high, indicating potential long-term growth opportunities.

### 4. Recent News & Significant Events

* [2026-01-27] UnitedHealth stock plunges, leads insurers lower after Trump Medicare spending plan surprise - Yahoo Finance
* [2026-01-27] Stock Market Today: Dow Loses 400 Points As UnitedHealth Tumbles; S&P 500 Sets A Record (Live Coverage) - Investor's Business Daily
* [2026-01-27] UnitedHealth posts modest earnings beat, soft revenue guidance as insurer plots turnaround - CNBC
* [2026-01-27] UnitedHealth stock tumbles on Q4 results (UNH:NYSE) - Seeking Alpha
* [2026-01-27] UnitedHealth Stock Plunges 20%â€”Here's What's Driving the Huge Decline - Investopedia
* [2026-01-27] How UNH Stock Returned $78 Billion To Shareholders - Forbes

### Analysis

The recent news and events suggest that UnitedHealth Group's stock has experienced a sharp decline due to concerns over Medicare spending and disappointing earnings. However, the company has still managed to return $78 billion to shareholders, indicating some level of resilience.

### 4-2. Analyst Opinions

* Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 1.93 (~Buy)
  - Opinions: 26
  - Target Price (avg/high/low): 391.85 / 444.00 / 280.00

### Analysis

The analyst consensus is buy, with an average target price of $391.85. The opinions suggest a moderate level of enthusiasm for the stock among analysts.

### 5. Recent Earnings Analysis

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-28 | 2.59 | 113.16 B$ |
| 2025-08-11 | 3.76 | 111.62 B$ |
| 2025-05-07 | 6.9 | 109.58 B$ |
| 2024-11-04 | 6.56 | 100.82 B$ |
| 2025-10-28 | 6.56 | 100.82 B$ |

### Analysis

The recent earnings have been mixed, with the company reporting a beat in the latest quarter but missing expectations the quarter prior. Revenue has been increasing, but at a slower rate.

### 6. Financial Information

#### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $113.16B | 18.24% |
| 2025-06-30 | $111.62B | 17.93% |
| 2025-03-31 | $109.58B | 21.70% |
| 2024-12-31 | $100.81B | 21.14% |
| 2024-09-30 | $100.82B | 22.84% |

#### Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $95.79B | 2.45% |
| 2025-06-30 | $94.72B | 3.60% |
| 2025-03-31 | $95.04B | 6.62% |
| 2024-12-31 | $92.66B | 5.98% |
| 2024-09-30 | $94.53B | 6.41% |

### Analysis

UnitedHealth Group's financials have been improving, with revenue increasing and profit margins expanding. The company's equity and return on equity (ROE) have also increased, indicating a strong capital position.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.